| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.94▲ | 9.94▲ | 9.92▲ | 10.13▲ | 11.32▼ |
| MA10 | 9.90▲ | 10.06▲ | 9.98▲ | 10.39▼ | N/A |
| MA20 | 10.01▲ | 10.00▲ | 9.93▲ | 10.98▼ | N/A |
| MA50 | 10.01▲ | 10.13▲ | 10.26▼ | N/A | N/A |
| MA100 | 10.17▼ | 10.62▼ | 11.01▼ | N/A | N/A |
| MA200 | 10.74▼ | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.010▲ | 0.042▲ | N/A | N/A |
| RSI | 57.567▲ | 52.974▲ | 51.367▲ | 43.710▼ | N/A |
| STOCH | 47.966 | 11.789▼ | 14.983▼ | 42.158 | N/A |
| WILL %R | -65.217 | -65.217 | -60.000 | -62.547 | N/A |
| CCI | 68.531 | 46.834 | 95.898 | -60.003 | N/A |
|
Thursday, July 09, 2026 05:16 AM
In regenerative medicine, the durable advantage rarely comes from a single product; it comes from a platform that can be pointed at more than ...
|
|
Wednesday, July 08, 2026 09:24 PM
Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) opened a new research and development facility at adMare BioInnovations’ M4 Innovation Centre, expanding the home of its ...
|
|
Tuesday, July 07, 2026 06:45 AM
Equity Insider News Commentary, The weight-loss drug boom is one of the defining medical stories of the decade, and its second-order effects are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 10.14 | 10.74 | 9.70 | 10.20 | 43,558 |
| 09/07/26 | 10.20 | 10.34 | 9.73 | 9.91 | 84,911 |
| 08/07/26 | 9.33 | 10.552 | 8.1401 | 10.24 | 157,502 |
| 07/07/26 | 11.1994 | 11.5099 | 9.25 | 9.49 | 335,141 |
| 06/07/26 | 10.87 | 11.20 | 10.61 | 10.80 | 41,027 |
| 02/07/26 | 10.87 | 11.32 | 10.55 | 10.86 | 70,196 |
| 01/07/26 | 10.5001 | 10.6534 | 9.9729 | 10.26 | 55,906 |
| 30/06/26 | 10.39 | 10.95 | 10.23 | 10.92 | 31,808 |
| 29/06/26 | 11.10 | 11.40 | 10.1837 | 10.24 | 43,371 |
| 26/06/26 | 10.22 | 11.254 | 10.105 | 10.96 | 36,588 |
|
|
||||
|
|
||||
|
|